Nivolumab
Products Nivolumab was approved in the United States in 2014 and in the in many countries and the EU in 2015 as a concentrate for the preparation of an infusion solution (Opdivo). Structure and properties Nivolumab is a human monoclonal antibody. It is an IgG4κ-immunoglobulin with a molecular mass of 146 kDa. Nivolumab is produced … Nivolumab
